Author

Lawrence Mendelsohn

Observed names: L A Mendelsohn, L Mendelsohn, Lawrence A. Mendelsohn

Institution: Central Arkansas Radiation Therapy Institute

Observed institutions: University of Kentucky, Lexington VA Health Care System, Markey Cancer Center, Central Arkansas Radiation Therapy Institute

OpenAlex ID: A5111995431

Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.

1987 · M E Marshall, L Mendelsohn, et al. · Journal of Clinical Oncology · 108

Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study

1989 · M.Ernest Marshall, Karen Butler, et al. · Cancer Chemotherapy and Pharmacology · 49

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial

2024 · Daniel H. Ahn, Maya Ridinger, et al. · Journal of Clinical Oncology · 28

Treatment of non-small cell lung cancer with coumarin and cimetidine.

1987 · M E Marshall, L Mendelsohn, et al. · PubMed · 18

A phase 1b/2 trial of the PLK1 inhibitor onvansertib in combination with FOLFIRI-bev in 2L treatment of KRAS-mutated (mKRAS) metastatic colorectal carcinoma (mCRC).

2022 · Heinz-Josef Lenz, Anup Kasi, et al. · Journal of Clinical Oncology · 8

Adjuvant therapy of gastrointestinal cancer

1987 · Edward H. Romond, Lawrence A. Mendelsohn, et al. · Cancer treatment and research · 4

Abstract 425: Expanded access program of the PLK1 inhibitor onvansertib for treatment of patients with KRAS-mutant metastatic colorectal cancer

2021 · Manish R. Sharma, Daniel Isaac, et al. · Cancer Research

Carcinoma of the breast with axillary lymph node metastasis.

1987 · L A Mendelsohn, W E Atkinson, et al. · PubMed

Works count: 8

Citation count: 215

H-index: 5

I10-index: 4